MedPath

Cystine Lithiasis in the Netherlands; Clinical and genetic aspects

Withdrawn
Conditions
cystinesteenlijden
cystinuria
10038360
10046708
Registration Number
NL-OMON36519
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

- Established diagnosis of cystinuria on the basis of amino acid chromatography with or without a history of nephrolithiasis;- Minors with an established diagnosis of cystinuria on the basis of amino acid chromatography will also be included after parent approval is obtained.

Exclusion Criteria

Geen

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Clinical endpoints:<br /><br>- Effect of magnitude of 24-hour urinary excretion of cystine on pattern of<br /><br>stone formation ( stone burden, frequency of spontaneous passage of stones,<br /><br>frequency of lithotripsy and/or urological interventions)<br /><br>- Long term effects of the metabolic abnormality on renal function of patients<br /><br>with an established diagnosis of cystinuria<br /><br>- Effectiveness of current management approaches on the above outcomes<br /><br>(endpoint 1)<br /><br><br /><br>Genetic endpoints:<br /><br>- Prevalence of known mutations.<br /><br>- Detection of new mutations.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath